Journal of Virological Methods 121 (2004) 85–91

Inactivation of the coronavirus that induces severe acute respiratory

syndrome, SARS-CoV
Miriam E.R. Darnella , Kanta Subbaraob , Stephen M. Feinstonea , Deborah R. Taylora,∗
a Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892, USA
b Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA

Received 27 May 2004; accepted 15 June 2004

Available online 3 August 2004

Abstract

Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by a novel coronavirus termed SARS-CoV. Due to the severity
of this disease, the World Health Organization (WHO) recommends that manipulation of active viral cultures of SARS-CoV be performed in
containment laboratories at biosafety level 3 (BSL3). The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 ◦ C or
greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments. We describe the kinetics of these efficient
viral inactivation methods, which will allow research with SARS-CoV containing materials, that are rendered non-infectious, to be conducted
at reduced safety levels.
© 2004 Elsevier B.V. All rights reserved.

Keywords: SARS; Coronavirus; Virus inactivation; Tissue culture

1. Introduction SARS-CoV, and there is a concern that another SARS out-

break could occur following an accidental exposure in a lab-
In late 2002, an outbreak of unusual life-threatening oratory. Since the end of the SARS epidemic in July 2003,
respiratory disease of unknown etiology began in Guang- there have been three known cases of SARS in laboratory
dong Province, China. This disease was designated severe researchers due to accidental exposure to the virus (Normile,
acute respiratory syndrome (SARS) and was later deter- 2004). Successful inactivation of the virus allows the trans-
mined by Drosten et al. (2003), Ksiazek et al. (2003), fer of material from a BSL3 to a BSL2 environment and may
and Rota et al. (2003), to be caused by a novel coro- reduce the risk of accidental infections through unsafe labo-
navirus, termed SARS-CoV. Since the identification of ratory practices. Inactivated cell-culture derived viral stocks
coronavirus as the infectious agent for SARS, numerous may also be useful for the development of vaccines and the
laboratories have begun research on this virus. Accord- study of their safety and immunogenicity. We examined the
ing to the WHO, 8098 people were diagnosed with SARS efficiency of several methods of viral inactivation, including
and 774 people died of this disease during the initial out- methods that may inhibit viral replication or entry.
break of 2003. Due to the severity of SARS disease and
the contagious nature of the causal agent, the WHO web-
site (http://www.who.int/csr/sars/biosafety2003 12 18/en/) 2. Materials and methods
has provided guidelines for working safely with this coro-
navirus. The WHO recommends biosafety level 3 (BSL3) 2.1. Virus and cells
as the appropriate containment level for working with live
We infected African green monkey kidney (Vero E6)
∗ Corresponding author. Tel.: +1 301 827 1878; fax: +1 301 496 1810. cells with SARS-CoV (Urbani strain) that was kindly pro-
E-mail address: taylord@cber.fda.gov (D.R. Taylor). vided by Drs. L.J. Anderson and T.G. Ksiazek from the

0166-0934/$ – see front matter © 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.jviromet.2004.06.006
86 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91

Centers for Disease Control and Prevention, Atlanta, GA. 2.5. Heat treatment of virus
Briefly, Vero E6 monolayer cells were infected by inoc-
ulating cultures with 50 ␮l of virus (106.33 TCID50 per We incubated 320 ␮l aliquots of virus in 1.5 ml polypropy-
ml) in a final volume of 5 ml Dulbecco’s modified Eagle’s lene cryotubes using a heating block to achieve three different
medium (DMEM) (Biosource International, Camarillo, CA) temperatures (56, 65 and 75 ◦ C). After heat treatment, sam-
in T150 flasks for 1 h at 25 ◦ C. Dulbecco’s modified Eagle’s ples were frozen for later analysis by TCID50 assay using
medium containing supplements (10% fetal bovine serum, CPE as an endpoint.
2 mM/ml l-glutamine, 100 U/ml penicillin, 100 ␮g/ml strep-
tomycin, and 0.5 ␮g/ml fungizone) (Biosource International) 2.6. Formaldehyde and glutaraldehyde treatment
was added to the flask and the cells were incubated at
37 ◦ C for 3 days. Supernatant was collected, clarified by Formaldehyde (37%, Mallinckrodt Baker, Inc., Paris, KY)
centrifugation, and stored at −70 ◦ C as the viral stock. and glutaraldehyde (8%, Sigma, Saint Louis, MO) were di-
The Vero cells were maintained in DMEM with supple- luted 1:10 and 1:40 in sterile PBS. These diluted aldehy-
ments. All personnel wore powered air-purifying respira- des were added to virus samples to achieve final dilutions
tors (3 M, Saint Paul, MN) and worked with infectious of 1:1000 and 1:4000 in 400 ␮l. The final concentrations of
virus inside a biosafety cabinet, within a BSL3 containment formaldehyde were 0.037% (1:1000) and 0.009% (1:4000),
facility. and the final concentrations of glutaraldehyde were 0.008%
(1:1000) and 0.002% (1:4000). The virus and aldehyde sam-
2.2. Quantitation of viral titers ples were incubated at 4, 25, and 37 ◦ C, for up to 3 days.
The samples were mixed briefly with a vortex on each day.
Viral titers were determined in Vero cell monolayers on The samples were stored at −70 ◦ C until analysis by TCID50
24 and 96-well plates using a 50% tissue culture infectious assay.
dose assay (TCID50 ). Serial dilutions of virus samples were
incubated at 37 ◦ C for 4 days and subsequently examined 2.7. pH treatment
for cytopathic effect (CPE) in infected cells, as described
by Ksiazek et al. (2003). Briefly, SARS-CoV-induced CPE Virus aliquots were adjusted to the desired pH using 5 M
of infected cells was determined by observing rounded, de- and 1 M HCl or 5N and 1N NaOH. Subsequently, they were
tached cells in close association to each other. Evidence of divided into three aliquots, incubated at the desired temper-
inactivation was determined by absence of CPE in Vero cells, ature (4, 25, and 37 ◦ C), neutralized to a pH 7, and analyzed
indicating loss of infectivity. for viral titer using the TCID50 assay.

2.3. UV light treatment 2.8. Infectivity of viral RNA and detergent-disrupted

virions
Ultraviolet light (UV) treatment was performed on 2 ml
aliquots of virus (volume depth = 1 cm) in 24-well plates Infected Vero cells were prepared by inoculation with
(Corning Inc., Corning, NY). The UV light source (Spec- 20 ␮l of virus at a 106.37 TCID50 per ml of SARS-CoV
tronics Corporation, Westbury, NY) was placed above the in a final volume of 2 ml in a T25 flask for 1 h at 25 ◦ C.
plate, at a distance of 3 cm from the bottom of the wells DMEM with supplements was added to the flask and the
containing the virus samples. At 3 cm our UVC light source cells were incubated at 37 ◦ C for 3 days. The monolayer
(254 nm) emitted 4016 ␮W/cm2 (where ␮W = 10−6 J/s) was washed with 1X phosphate buffered saline (PBS),
and the UVA light source (365 nm) emitted 2133 ␮W/cm2 , cells were lysed with the addition of 2.5 ml of a phenol
as measured by radiometric analysis (Spectronics Corpo- and guanidine isothiocyanate solution (TRIzol Reagent,
ration). After exposure to the UV light source, virus was Sigma), and cytoplasmic RNA was isolated according to the
frozen for later analysis by TCID50 assay using CPE as the manufacturer’s specifications. Vero cells were inoculated
endpoint. with 10 ␮l of purified RNA in 0.5 ml DMEM. After an
hour, DMEM with supplements was added. Additionally,
2.4. Gamma irradiation treatment Vero cells were transfected with cytoplasmic RNA using
DMRIE-C (Invitrogen Life Technologies, Carlsbad, CA)
We prepared 400 ␮l samples of SARS-CoV and kept them according to the manufacturer’s instructions. Cells were
on dry ice during transport. Test samples were subjected to incubated at 37 ◦ C, and observed for CPE on days 3 and 4.
gamma radiation (3000, 5000, 10,000, and 15,000 rad) from To examine the infectivity of detergent-disrupted virions,
a 60 Co source, while control samples were protected from SARS-CoV infected Vero monolayer cells were washed and
exposure. Test and control samples were handled and trans- dissociated with trypsin/versene, pelleted by centrifugation,
ported identically, except test samples were exposed to the and washed with PBS. After centrifugation, the pellet was
gamma radiation source. Samples were kept frozen until anal- lysed with sodium dodecyl sulfate/nonidet P-40 (SDS/NP-
ysis of inactivation by TCID50 assay. 40; 0.1% SDS, 0.1% NP-40, in 0.1x PBS; Sigma), frozen
 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91 87

at −70 ◦ C, thawed, and clarified by centrifugation. The su-

pernatant was used to infect Vero cell monolayers in 6-well
plates, such that the final concentration of SDS was 0.002 or
0.018%. Three and four days following the inoculation, cells
were observed for evidence of CPE.

3. Results

3.1. Effect of radiation on the infectivity of SARS-CoV

UV light is divided into three classifications: UVA

(320–400 nm), UVB (280–320 nm), and UVC (200–280 nm).
UVC is absorbed by RNA and DNA bases, and can cause
the photochemical fusion of two adjacent pyrimidines into
covalently linked dimers, which then become non-pairing
bases (Perdiz et al., 2000). UVB can cause the induction of
pyrimidine dimers, but 20–100-fold less efficiently than UVC
(Perdiz et al., 2000). UVA is weakly absorbed by DNA and
RNA, and is much less effective than UVC and UVB in in-
ducing pyrimidine dimers, but may cause additional genetic
damage through the production of reactive oxygen species,
which cause oxidization of bases and strand breaks (Tyrrell
Fig. 1. Effect of radiation on the infectivity of SARS-CoV. (A) UV irradi-
et al., 2001).
ation. The UV lamp was placed 3 cm above the bottom of 24-well plates
To examine the inactivation potential of UVA and UVC, containing 2 ml virus aliquots. Samples were removed at each time point,
virus stocks were placed in 24-well tissue culture plates and frozen, and titrated in Vero E6 cells. The results shown are representative
exposed to UV irradiation on ice for varying amounts of of three independent experiments. (B) Gamma irradiation. Virus aliquots
time, as indicated in Fig. 1A. Exposure of virus to UVC (400 ␮l) were placed in cryovials on dry ice and exposed to the indicated
dose of gamma irradiation. Control samples were treated identically, without
light resulted in partial inactivation at 1 min with increas-
radiation exposure. Samples were titrated in Vero E6 cells in triplicate. The
ing efficiency up to 6 min (Fig. 1A), resulting in a 400-fold dotted line denotes the limit of detection of the assay.
decrease in infectious virus. No additional inactivation was
observed from 6 to 10 min. After 15 min the virus was com- We found that at 56 ◦ C most of the virus was inactivated after
pletely inactivated to the limit of detection of the assay, which 20 min (Fig. 2A). However, the virus remained infectious at
is ≤1.0 TCID50 (log10 ) per ml. In contrast, UVA exposure a level close to the limit of detection for the assay, for at least
demonstrated no significant effects on virus inactivation over 60 min, suggesting that some virus particles were stable at
a 15 min period. Our data show that UVC light inactivated 56 ◦ C (Fig. 2A and C). At 65 ◦ C, most of the virus was inac-
the SARS virus at a distance of 3 cm for 15 min. tivated if incubated for longer than 4 min (Fig. 2B). Again,
A standard procedure to inactivate viruses during the man- some infectious virus could still be detected close to the limit
ufacture of biological products is gamma irradiation (Grieb et of detection for the assay, after 20 min at 65 ◦ C. While virus
al., 2002). To investigate the effect of gamma irradiation on was incompletely inactivated at 56 and 65 ◦ C even at 60 min,
SARS-CoV, we subjected 400 ␮l of SARS-CoV to gamma it was completely inactivated at 75 ◦ C in 45 min (Fig. 2C).
radiation (3000, 5000, 10,000, and 15,000 rad) from a 60 Co Surprisingly, at both 56 and 65 ◦ C the virus was inactivated
source, while control samples were protected from exposure. at early time points but at 60 min a small amount of virus
No effect on viral infectivity was observed within this range was detected. One possible explanation for this result may
of gamma irradiation exposure (Fig. 1B). be the presence and subsequent dissociation of aggregates.
Taken together, these results suggest that viral inactivation
3.2. Effect of heat treatment on the infectivity of by pasteurization may be very effective.
SARS-CoV
3.3. Effects of formaldehyde and glutaraldehyde on the
Heat can inactivate viruses by denaturing the secondary infectivity of SARS-CoV
structures of proteins, and thereby may alter the conforma-
tion of virion proteins involved in attachment and replication Formalin (dilute formaldehyde) has been used for a num-
within a host cell (Lelie et al., 1987; Schlegel et al., 2001). To ber of years to inactivate virus for use in vaccine products,
test the ability of heat to inactivate the SARS-CoV, we incu- such as the widely used and very effective polio vaccine (Salk
bated virus in 1.5 ml polypropylene cryotubes at three tem- and Salk, 1984). Other attempts at using formalin inactivation
peratures (56, 65 and 75 ◦ C) for increasing periods of time. for generation of vaccines for respiratory syncytial virus (Kim
88 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91

1.14 ± 0.29

2.78 ± 0.14
37 ◦ C

≤1.0
≤1.0
≤1.0
x
x
1.14 ± 0.29

4.1 ± 0.52
25 ◦ C

≤1.0
≤1.0
≤1.0
x
x
3.28 ± 0.14

2.19 ± 0.25
5.12 ± 0.14
Day 3

≤1.0
≤1.0
4 ◦C

x
x

3.36 ± 0.29
1.5 ± 0
37 ◦ C

≤1.0
≤1.0
≤1.0
x
x
1.31 ± 0.29

4.86 ± 0.29
25 ◦ C

≤1.0
≤1.0
≤1.0
x
x
4.02 ± 0.38

2.26 ± 0.38
5.03 ± 0.14

Fig. 2. Effect of heat treatment on the infectivity of SARS-CoV. Virus

Day 2

≤1.0
≤1.0
4 ◦C

aliquots (400 ␮l) were incubated at (A, C) 56 ◦ C, (B, C) 65 ◦ C and (C)

Formaldehyde treatment fixed the cells in the TCID50 assay so virus could not be detected.
x
x

75 ◦ C. Samples were removed at the designated time, frozen, and titrated in

Vero E6 cells in triplicate. The dotted line denotes the limit of detection of
the assay.
4.03 ± 0.14
1.31 ±0.29

et al., 1969) and measles virus (Fulginiti et al., 1967) were not
37 ◦ C

≤1.0
≤1.0
≤1.0

useful, as they induced an aberrant immune response result-

x
x

ing from formalin-induced perturbations of the viruses. For-

Effect of formaldehyde and glutaraldehyde inactivation of SARS-CoV

malin inactivation occurs when nonprotonated amino groups

of amino acids, such as lysine, combine with formaldehyde to
1.31 ± 0.29

1.31 ± 0.29
5.09 ± 0.58

form hydroxymethylamine. The hydroxymethylamine com-

25 ◦ C

bines with the amino, amide, guanidyl, phenolic, or imidazole

≤1.0
≤1.0

The limit of detection for the TCID50 assay is ≤1.0.

group of amino acids to create inter- or intramolecular methy-

x
x

lene crosslinks (for review, see Jiang and Schwendeman,

Geometric mean of triplicate samples ± S.D.

2000). Fraenkel-Conrat (1954) observed the absorption spec-

4.45 ± 0.25b

5.28 ± 0.29

tra of several plant viruses and determined that formalin also

2.70 ± 0

binds in a reversible manner to RNA, blocking reading of

Day 1

≤1.0c
≤1.0
4 ◦C

the genome by RNA polymerase. Glutaraldehyde can also be

xa
x

used to inactivate virus and is used as a disinfecting agent

of medical instruments, such as endoscopes (Tandon, 2000),
Glutaraldehyde treatment

and as a fixative for electron microscopy (McDonnell and

Formaldehyde treatment
Dilution

1:1000
1:1000
1:4000

1:1000
1:1000
1:4000

Russell, 1999).
No

We examined formalin and glutaraldehyde inactivation of

the SARS-CoV by incubating virus samples with formalin or
glutaraldehyde at two different dilutions (1:1000 and 1:4000).
Table 1

Yes
Yes

Yes
Yes
Yes

Each of the diluted aldehydes was incubated with virus at 4,

No

No
Virus

b
c
a

25 or 37 ◦ C. Both of the aldehydes exhibited temperature de-

 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91 89

pendence in their ability to inactivate virus (Table 1). Neither infected cells. We used a phenol and guanidine isothiocyanate
formalin nor glutaraldehyde, at a 1:4000 dilution, was able to solution (TRIzol, Sigma) to isolate cytoplasmic RNA from
completely inactivate virus at 4 ◦ C, even after exposure for 3 SARS-CoV infected Vero cells. After inoculation of Vero
days (Table 1). At 25 and 37 ◦ C, formalin inactivated most of cells with the isolated RNA, we determined that SARS-CoV
the virus, close to the limit of detection of the assay, after 1 RNA was not able to produce CPE in the cells (data not
day, yet some virus still remained infectious on day 3. How- shown). We also found that transfection of the cells with this
ever, glutaraldehyde completely inactivated the virus by day RNA, using a liposome-based transfection reagent (DMRIE-
2 at 25 ◦ C and by day 1 at 37 ◦ C. This suggests that both for- C, Invitrogen, as per manufacturer’s instructions for RNA
malin and glutaraldehyde inactivation of SARS virus may be transfection), was also not sufficient to cause infection of
efficient methods of inactivation, if proper conditions are met. Vero cells (data not shown).
Additionally, we tested the effectiveness of SDS/NP-40
3.4. Effect of pH changes on the infectivity of SARS treatment on inactivation of the SARS-CoV. Briefly, SARS-
CoV-infected Vero cells were lysed with an SDS/NP-40 solu-
Weismiller et al. (1990) determined that a pH of 8.0 in- tion, clarified by centrifugation, and the supernatant was used
duces a conformational change in the spike protein of the to infect Vero cell monolayers. No CPE was observed in the
coronavirus, mouse hepatitis virus (MHV), which enables cells after 3 and 4 days, indicating that SDS/NP-40-induced
fusion of the virion with the host cell. However, Xiao et al. disruption of the virions was sufficient to prevent survival of
(2003) determined that the spike protein of SARS-CoV me- infectious particles.
diated fusion with the host cell at a neutral pH. These data
suggest that different pH conditions affect the spike proteins
of coronaviruses, and the activity of the spike protein of the 4. Discussion
SARS-CoV may be sensitive to changes in pH, possibly by
changing the infectious nature of the viral particles. There- Inactivation of SARS-CoV can be achieved through a
fore, we investigated the effect of different pH exposures on number of techniques, given sufficient time and appropri-
the infectivity of SARS-CoV. After exposing SARS-CoV to ate temperature conditions. We caution that the inactivation
extreme alkaline conditions of pH 12 and 14 for 1 h, and sub- procedures discussed above were performed under specific
sequently reversing the conditions to a neutralized, buffered conditions. Due to the grave consequences of a potential
solution, the virus was completely inactivated (Fig. 3). Mod- SARS-CoV human infection, great care should be taken to
erate variations of pH conditions from 5 to 9 had little effect ensure that any inactivation procedures used to make the virus
on virus titer, regardless of the temperature. However, highly safe for BSL2 conditions are effective for each viral stock.
acidic pH conditions of 1 and 3 completely inactivated the We determined that greater than 15 min of UVC treatment
virus at 25 and 37 ◦ C. At 4 ◦ C, a pH of 3 did not fully in- inactivated the virus while UVA light had no effect on via-
activate the virus. These data indicate that the infectivity of bility, regardless of duration of exposure. Duan et al. (2003)
SARS-CoV is sensitive to pH extremes. examined the effect of UVC light on SARS-CoV at an inten-
sity of >90 ␮W/cm2 and a distance of 80 cm, and determined
3.5. Infectivity of isolated viral RNA and isolated
that inactivation of the virus occurred at 60 min. Inactivation
proteins
may have occurred more efficiently in our study due to the
Biochemical and molecular biology experiments may re- greater intensity of UVC light and the closer proximity of the
quire the isolation of nucleic acids or proteins from virus- light source. We also examined the effect of gamma irradia-
tion on SARS-CoV, and found no decrease in infectivity at
the highest dose of 15,000 rad. This result was not surpris-
ing, as the Centers for Disease Control and Prevention have
used a much higher dose of 2 × 106 rad to inactivate poten-
tial SARS-CoV-infected serum specimens for study in BSL2
laboratories (Ksiazek et al., 2003). This dosage is in the same
range (3–4.5 × 106 rad) that is necessary to inactivate viruses
in monoclonal antibody preparations (Grieb et al., 2002) and
bone diaphysis transplants (Pruss et al., 2002).
Our experiments showed that heat treatment of SARS-
CoV for 45 min at 75 ◦ C resulted in inactivation of the virus,
while 90 min at 56 and 65 ◦ C was required for virus inac-
tivation. Laude (1981) determined that thermal inactivation
Fig. 3. Effect of pH conditions on the infectivity of SARS-CoV. Virus
of another coronavirus, transmissible gastroenteritis virus of
aliquots (2 ml) were adjusted to the indicated pH condition, divided into
triplicate samples, incubated at the designated temperature for 1 h, neutral- swine, also occurred faster at higher temperatures, such as 47
ized, frozen, and titrated. The dotted line denotes the limit of detection of and 55 ◦ C, than at the lower temperature of 31 ◦ C. Our data
the assay. are similar to the findings of Duan et al. (2003), wherein viral
90 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91

inactivation occurred at 90, 60, and 30 min after incubation CoV can be inactivated, will allow the transfer of the virus
at 56, 65, and 75 ◦ C, respectively. Heat is an effective means from BSL3 to BSL2 conditions, and will promote the study
of SARS-CoV inactivation, however, stocks containing viral of inactivated viral vaccines.
aggregates may require a longer duration of heat exposure.
We determined that formalin and glutaraldehyde inacti-
vated SARS-CoV in a temperature- and time-dependent man- Acknowledgements
ner. While incubation at 4 ◦ C inhibited the effect of these
chemicals, at 37 ◦ C or room temperature, formalin signifi- We thank Spectronics Corporation for the use of UV lamps
cantly decreased the infectivity of the virus on day 1, while and radiometer. We also thank Leatrice Vogel and Josephine
glutaraldehyde inactivated SARS-CoV after incubations of McAuliffe for technical assistance, Montserrat Puig for help-
1–2 days. As glutaraldehyde is commonly used to disinfect ful suggestions and Kathryn Carbone, Jesse Goodman, Bill
medical instruments, especially endoscopes, care should be Egan and Jerry Weir for their support.
taken to analyze time, temperature, and concentration re-
quirements necessary for complete SARS-CoV inactivation.
Weismiller et al. (1990) determined that a pH of 8.0 in- References
duces a conformational change in the spike protein of the
coronavirus MHV that enables fusion of the virion with the Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H.-R.,
host cell. However, Xiao et al. (2003) determined that the Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier,
R.A.M., Berger, A., Burguiere, A.-M., Cinatl, J., Eickmann, M.,
spike protein of SARS-CoV mediated fusion with the host Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Muller,
cell at a neutral pH. These data suggest that different pH S., Rickerts, V., Sturmer, M., Vieth, S., Klenk, H.-D., Osterhaus,
conditions affect the spike proteins of coronaviruses, and the A.D.M.E., Schmitz, H., Doerr, H.W., 2003. Identification of a novel
activity of the spike protein of SARS-CoV may be sensitive coronavirus in patients with severe acute respiratory syndrome. N.
to changes in pH, possibly by changing the infectious na- Engl. J. Med. 348, 1967–1976.
Duan, S.-M., Zhao, X.-S., Wen, R.-F., Huang, J.-J., Pi, G.-H., Zhang,
ture of the viral particles. We determined that exposure of S.-X., Han, J., Bi, S.-L., Ruan, L., Dong, X.-P., and SARS Research
SARS-CoV to extreme basic or acidic conditions caused in- Team, 2003. Stability of SARS coronavirus in human specimens and
activation, while the virus remained stable within a range of environment and its sensitivity to heating and UV irradiation. Biomed.
neutral pH. The pH of gastric secretions of the stomach ranges Environ. Sci. 16, 246–255.
from 1.0 to 3.5, while the small and large intestines range Fraenkel-Conrat, H., 1954. Reaction of nucleic acid with formaldehyde.
Biochim. Biophys. Acta 15, 307–309.
from pH 7.5 to 8.0 (Guyton and Hall, 1997). Taken together, Fulginiti, V.A., Eller, J.J., Downie, A.W., Kempe, C.H., 1967. Altered
these data suggest that ingestion of SARS-CoV would prob- reactivity to measles virus: atypical measles in children previously
ably result in inactivation of most virions by stomach acid. immunized with inactivated measles virus vaccines. JAMA 202,
However, acidic conditions of the stomach may be partially 1075–1080.
neutralized by a particularly large meal or antacid ingestion, Grieb, T., Forng, R.-Y., Brown, R., Owolabi, T., Maddox, E., McBain,
A., Drohan, W.N., Mann, D.M., Burgess, W.H., 2002. Effective use of
and under these conditions the virus might have a chance to gamma irradiation for pathogen inactivation of monoclonal antibody
move through the stomach into the slightly basic conditions preparations. Biologicals 30, 207–216.
of the intestines. Leung et al. (2003) have shown enteric in- Guyton, A.C., Hall, J.E., 1997. Secertory fuction of the alimentary tract.
volvement of the SARS virus, as evidenced by the presence Human Physiology and Mechanisms of Disease, sixth ed. W.B. Saun-
of active viral replication in intestinal biopsy specimens from ders Company, Philadelphia (pp. 524–536).
Jiang, W., Schwendeman, S.P., 2000. Formaldehyde-mediated aggregation
five patients, and the isolation of SARS-CoV RNA in stool of protein antigens: comparison of untreated and formalinized model
specimens up to 10 weeks after onset of symptoms. These antigens. Biotechnol. Bioeng. 70, 507–517.
data, coupled with the previously mentioned stability of the Kim, H.W., Canchola, J.G., Brandt, C.D., Pyles, G., Chanock, R.M.,
virus to moderate pH conditions, suggest that the SARS virus Jensen, K., Parrott, R.H., 1969. Respiratory syncytial virus disease in
may survive ingestion and a fecal/oral route of infection may infants despite prior administration of antigenic inactivated vaccine.
Am. J. Epidemiol. 89, 422–434.
be possible. Ksiazek, T.G., Erdman, D., Goldsmith, C.S., Zaki, S.R., Peret, T., Emery,
Our experiments showed that UVC light, heat, formalin, S., Tong, S., Urbani, C., Comer, J.A., Lim, W., Rollin, P.E., Dowell,
glutaraldehyde, and extremes of pH, were able to inactivate S.F., Ling, A.-E., Humphrey, C.D., Shieh, W.-J., Guarner, J., Pad-
SARS-CoV. However, gamma irradiation at the doses tested, dock, C.D., Rota, P., Fields, B., DeRisi, J., Yang, J.-Y., Cox, N.,
was not sufficient to inactivate the virus. As expected, nei- Hughes, J.M., LeDuc, J.W., Bellini, W.J., Anderson, L.J., and the
SARS Working Group, 2003. A novel coronavirus associated with
ther viral RNA alone nor virions disrupted by SDS/NP-40 severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–
were infectious. These conditions were appropriate for our vi- 1966.
ral stocks as described, however, we caution that researchers Laude, H., 1981. Thermal inactivation studies of a coronavirus, transmis-
need to test viral stocks for complete inactivation before han- sible gastroenteritis virus. J. Gen. Virol. 56, 235–240.
dling the virus at lower safety levels. These data analyze virus Lelie, P.N., Reesink, H.W., Lucas, C.J., 1987. Inactivation of 12 viruses
by heating steps applied during manufacture of a hepatitis B vaccine.
samples in tissue culture medium and we are currently testing J. Med. Virol. 23, 297–301.
the inactivation properties required of SARS-CoV in biolog- Leung, W.K., To, K.-F., Chan, P.K.S., Chan, H.L.Y., Wu, A.K.L., Lee, N.,
ical (body) fluids. Understanding the ways in which SARS- Yuen, K.Y., Sung, J.J.Y., 2003. Enteric involvement of severe acute
 M.E.R. Darnell et al. / Journal of Virological Methods 121 (2004) 85–91 91

respiratory syndrome-associated coronavirus infection. Gastroenterol- haus, A.D.M.E., Drosten, C., Pallansch, M.A., Anderson, L.J., Bellini,
ogy 125, 1011–1017. W.J., 2003. Characterization of a novel coronavirus associated with
McDonnell, G., Russell, A.D., 1999. Antiseptics and disinfectants: activ- severe acute respiratory syndrome. Science 300, 1394–1399.
ity, action, and resistance. Clin. Micro. Rev. 12, 147–179. Salk, D., Salk, J., 1984. Vaccinology of poliomyelitis. Vaccine 2, 59–74.
Normile, D., 2004. Mounting lab accidents raise SARS fears. Science Schlegel, A., Immelmann, A., Kempf, C., 2001. Virus inactivation of
304, 659–661. plasma-derived proteins by pasteurizaion in the presence of guanidine
Perdiz, D., Grof, P., Mezzina, M., Nikaido, O., Moustacchi, E., Sage, hydrochloride. Transfusion 41, 382–389.
E., 2000. Distribution and repair of bipyrimidine photoproducts in Tandon, R.K., 2000. Disinfection of gastrointestinal endoscopes and ac-
solar UV-irradiated mammalian cells. J. Biol. Chem. 275, 26732– cessories. J. Gastroenterol. Hepatol. 15, 69–72.
26742. Tyrrell, J.-L., Douki, T., Cadet, J., 2001. Direct and indirect effects of
Pruss, A., Kao, M., Gohs, U., Koscielny, J., von Versen, R., Pauli, G., UV radiation on DNA and its components. J. Photochem. Photobiol.
2002. Effect of gamma irradiation on human cortical bone transplants B 63, 88–102.
contaminated with enveloped and non-enveloped viruses. Biologicals Weismiller, D.J., Sturman, L.S., Buchmeier, M.J., Fleming, J.O., Holmes,
30, 125–133. K.V., 1990. Monoclonal antibodies to the peplomer glycoprotein of
Rota, P.A., Oberste, M.S., Monroe, S.S., Nix, W.A., Campagnoli, R., coronavirus mouse hepatitis virus identify two subunits and detect
Icenogle, J.P., Penaranda, S., Bankamp, B., Maher, K., Chen, M.- a conformational change in the subunit released under mild alkaline
H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J.L., Chen, conditions. J. Virol. 64, 3051–3055.
Q., Wang, D., Erdman, D.D., Peret, T.C.T., Burns, C., Ksiazek, T.G., Xiao, X., Chakraborti, S., Dimitrov, A.S., Gramatikoff, K., Dimitrov, D.S.,
Rollin, P.E., Sanchez, A., Liffick, S., Holloway, B., Limor, J., Mc- 2003. The SARS-CoV S glycoprotein: expression and functional char-
Caustland, K., Olsen-Rasmussen, M., Fouchier, R., Gunther, S., Oster- acterization. Biochem. Biophys. Res. Commun. 312, 1159–1164.
 HHS Public Access
Author manuscript
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 May 01.
Author Manuscript

Published in final edited form as:

Infect Control Hosp Epidemiol. 2016 May ; 37(5): 598–599. doi:10.1017/ice.2015.348.

Efficacy of an automated multi-emitter whole room UV-C

disinfection system against Coronaviruses MHV and MERS-CoV
Kurt Bedell1, Adam Buchaklian, PhD2, and Stanley Perlman, MD, PhD1,3
1Department of Microbiology University of Iowa, Iowa City, IA 52242
2Surfacide LLC, Waukesha, Wisconsin
Author Manuscript

3Department of Microbiology Pediatrics, University of Iowa, Iowa City, IA 52242

Abstract
The virus responsible for Middle Eastern respiratory syndrome, MERS-CoV is a lineage C
betacoronavirus similar to the mouse hepatitis virus type A59 (MHV-A59). The first reported case
of MERS occurred in Saudi Arabia in 2012 and resulted in 76 deaths1. Outbreaks of MERS have
since occurred not only in the Middle East but South Korea as well2. Rapid, efficient, and
automated methods of disinfecting surfaces contaminated with the MERS-CoV virus may prevent
the spread of the virus in the healthcare setting. Here we report on the use of an automated triple-
emitter whole room disinfection system to inactivate the MHV-A59 and the MERS-CoV viruses
on surfaces with a greater than 5 log10 reduction on MERS in 5 minutes of UV-C exposure.
Author Manuscript

Introduction
Coronaviruses like MHV-A59 were first identified as the causative agents in outbreaks of
Severe Acute Respiratory Syndrome (SARS) in 2002 in China, and Middle Eastern
Respiratory Syndrome (MERS) in the Middle East in 2012 3–5. Since that time outbreaks of
MERS have continued to occur in both the Middle East as well as in South Korea and China.
MERS has a reported mortality rate of approximately 40%4–6.

MERS is thought to be transmitted from camels to humans through direct contact, however
obvious camel to human interaction has not been documented in all cases. Human-human
transmission has also been identified in hospital and household transmission during MERS
outbreaks. The ability of Coronaviruses to rapidly mutate increases the risk of a pandemic
Author Manuscript

outbreak in the near future 4. MHV-A59 is structurally similar to the MERS-CoV but causes
hepatic and neuronal tropic disease in mice. It has been shown to also induce acute
pneumonia and severe lung injuries similar to MERS in humans when given by intranasal
inoculation to mice7. The MHV-A59 virus is an ideal model virus to study the effects of
Surfacide UV-C against MERS. Along with studies of MHV-A59 the Surfacide multiple
emitter system was also tested against the MERS-CoV virus.

Corresponding author: Adam Buchaklian, PhD, Surfacide, LLC, 407 Pilot Ct., Waukesha, WI 53188,
adam.buchaklian@surfacide.com.
 Bedell et al. Page 2

The Study
Author Manuscript

Triplicate 10μl aliquots of MHV-A59 were loaded onto sterile glass coverslips at a
concentration of 1.6e8 pfu/ml and allowed to dry. MHV-A59 was stable when dried on glass
coverslips for at least 60 minutes. Coverslips containing dried virus were then placed in a
UV transparent petri dish (Sarstedt) and either left untreated or exposed to UV-C radiation
from the Surfacide system for predetermined times between 0 and 60 minutes. The
coverslips containing dried virus were then placed in DMEM media on ice to re-suspend the
virus. Serial 1:10 dilutions were inoculated onto Hela cells and allowed to incubate for 45
minutes at 37°C. Media containing virus was removed and the cells were allowed to
incubate overnight in D10 media. Plaque counts were determined the following day by
combining 1% neutral red with 2× media plus agarose and incubating the cells for
approximately 3 hours. All studies were conducted in triplicate with replicate experiments.
Plaque counts indicated that the UV-C energy emitted from the Surfacide disinfection device
Author Manuscript

was able to reduce the viral titers by an average of 2.71 log10 in 5 minutes and 6.11 log10 in
10 minutes of exposure (Figure 1).

Testing MERS-CoV sensitivity to UV-C virus was conducted under strict containment
protocols due to the infective nature of the virus and all steps were carried out above bleach
soaked pads to prevent virus spread. The presence of bleach in the biosafety cabinet
prevented drying of the virus onto glass coverslips. MERS-CoV was therefore loaded onto
glass coverslips as small droplets, placed in UV-C permeable dishes and exposed to UV-C
energy from the Surfacide emitter at a distance of 4-feet (1.22) and samples removed at
several time points between 0 and 30 minutes. Virus resuspension and dilution was carried
out as described above. Virus dilutions were placed onto 90% confluent Vero cells at 37°C
for 40 minutes. Following the 40 min incubation media containing virus was removed and
Author Manuscript

replaced with 2× medium plus 1.2% agarose and allowed to solidify. DMEM was then
layered on top to prevent drying and the plates incubated at 37°C for 3 days to allow for
plaque formation. On the third day formalin was added to fix the cells for 20 minutes.
Formalin, media, and agarose were then removed and replaced with 0.1% crystal violet for a
5 min incubation followed by a PBS wash prior to counting plaques. Again all samples were
prepared in triplicate. A UV-C exposure time of only 5 minutes resulted in undetectable
virus levels that remained undetectable following 30 minutes of total exposure for a 5.9
log10 reduction. (Figure 2).

Conclusions
The Surfacide triple emitter continuous UV-C disinfection system was greater than 99.999%
effective against MHV-A59, a mouse analog of MERS-CoV and SARS-CoV in 10 minutes.
Author Manuscript

Applying those same studies to droplets of MERS-CoV resulted in undetectable levels of

MERS-CoV virus after only 5 minutes of exposure to the Surfacide UV-C emitter or a
percent reduction of greater than 99.999%. This study is the first to document the
effectiveness of the Surfacide automated whole room UV-C system or any whole room
disinfection system against RNA viruses like MHV-A59, MERS-CoV and SARS-CoV. The
use of the Surfacide whole room UV-C disinfection system during MERS outbreaks may
prevent the nosocomial spread of the virus and protect staff in the process.

Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 May 01.
 Bedell et al. Page 3

References
Author Manuscript

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RaM. Isolation of a Novel
Coronavirus from a Man with Pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814–
1820. DOI: 10.1056/NEJMoa1211721 [PubMed: 23075143]
2. Khan A, Farooqui A, Guan Y, Kelvin DJ. Lessons to learn from MERS-CoV outbreak in South
Korea. J Infect Dev Ctries. 2015; 9(06):7–10. DOI: 10.3855/jidc.7278
3. Nie QH, Luo XD, Hui WL. Advances in clinical diagnosis and treatment of severe acute respiratory
syndrome. World J Gastroenterol. 2003; 9(6):1139–1143. http://www.ncbi.nlm.nih.gov/pubmed/
12800213. [PubMed: 12800213]
4. De Groot RJ, Baker SC, Baric RS, et al. Middle East Respiratory Syndrome Coronavirus (MERS-
CoV); Announcement of the Coronavirus Study Group. J Virol. 2013; 5(May):13–15. DOI:
10.1128/JVI.01244-13
5. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015; 386(9997):995–
1007. DOI: 10.1016/S0140-6736(15)60454-8 [PubMed: 26049252]
6. Memish, Za, Al-Tawfiq, Ja, Alhakeem, RF., et al. Middle East respiratory syndrome coronavirus
Author Manuscript

(MERS-CoV): A cluster analysis with implications for global management of suspected cases.
Travel Med Infect Dis. 2015; 13(4):311–314. DOI: 10.1016/j.tmaid.2015.06.012 [PubMed:
26211569]
7. Yang Z, Du J, Chen G, et al. Coronavirus MHV-A59 infects the lung and causes severe pneumonia
in C57BL/6 mice. Virol Sin. 2014; 29(6):393–402. DOI: 10.1007/s12250-014-3530-y [PubMed:
25547683]
Author Manuscript
Author Manuscript

Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 May 01.
 Bedell et al. Page 4
Author Manuscript
Author Manuscript

Figure 1.
Author Manuscript

Log reduction of MHV-A59 following Surfacide UV-C exposure at a 4-foot distance (1.22
meters). Virus was reduced by 2.71 log10 in 5 minutes and 6.11 log10 reduction in 10
minutes to undetectable levels.
Author Manuscript

Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 May 01.
 Bedell et al. Page 5
Author Manuscript
Author Manuscript

Figure 2.
Author Manuscript

Log reduction of MERS-CoV following Surfacide UV-C exposure at a 4-foot distance. Virus
was reduced to 5.91 log10 in 5 minutes to undetectable levels.
Author Manuscript

Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2017 May 01.